# EDGAR Filing Document

**Accession Number:** 0001505065
**File Stem:** 0001171843-23-001769
**Filing Date:** 2023-3
**Character Count:** 7823
**Document Hash:** f32e828660e385f1e70e841b13201d5d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001171843-23-001769.hdr.sgml**: 20230320

**ACCESSION NUMBER**: 0001171843-23-001769

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230320

**FILED AS OF DATE**: 20230320

**DATE AS OF CHANGE**: 20230320

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Brainsway Ltd.
- **CENTRAL INDEX KEY:** 0001505065
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 000000000

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35165
- **FILM NUMBER:** 23746385

**BUSINESS ADDRESS:**
- **STREET 1:** 19 HARTUM STREET, BYNET BUILDING, 3RD FL
- **STREET 2:** Har HaHotzvim
- **CITY:** Jerusalem
- **STATE:** L3
- **ZIP:** 91451
- **BUSINESS PHONE:** 972 2 581-3140

**MAIL ADDRESS:**
- **STREET 1:** 19 HARTUM STREET, BYNET BUILDING, 3RD FL
- **STREET 2:** Har HaHotzvim
- **CITY:** Jerusalem
- **STATE:** L3
- **ZIP:** 91451

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION<br> Washington, D.C. 20549**

**FORM 6-K**

**Report of Foreign Private Issuer<br> Pursuant to Rule 13a-16 or 15d-16<br> of the Securities Exchange Act of 1934**

For the month of March 2023<br> Commission File No.: 001-35165

**BRAINSWAY LTD.**<br> (Translation of registrant's name into English)

**19 Hartum Street<br> Bynet Building, 3rd Floor<br> Har HaHotzvim<br> Jerusalem, 9777518, Israel**

**(+972-2) 582-4030**<br> (Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.<br> Form 20-F [ X ] Form 40-F [ ]

**CONTENTS**

***Results of Annual Shareholder Meeting***

At the Annual General Meeting of Shareholders of BrainsWay Ltd. (the "**Company**") held on March 20, 2023, <u>all</u> proposed resolutions were approved by the required majority of the shareholders. Below are the proposals which were adopted, as well as the respective share of support each resolution received:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) To appoint Kost Forer Gabbay & Kasierer, certified public accountants in Israel and a member of Ernst & Young Global, as the Company's independent auditors for the year 2022 and for an additional period until the following annual general meeting and to authorize the Board of Directors to determine their compensation for the year; and to inform the shareholders of the aggregate compensation paid to the auditors for the year ended December 31, 2021.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 16,721,913 | 22,074 | 200 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) To approve the election or re-election of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Mr. Ami Boehm as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 16,702,841 | 22,326 | 4,040 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Dr. David Zacut as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 16,075,541 | 663,626 | 5,020 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Mr. Avner Hagai as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 16,075,177 | 663,626 | 5,384 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Mr. Avner Lushi as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 16,076,441 | 662,726 | 5,020 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Ms. Eti Mitrany as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 16,077,097 | 662,070 | 5,020 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Ms. Karen Sarid as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 16,076,775 | 662,028 | 5,020 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Prof. Avraham Zangen as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 16,076,841 | 663,326 | 4,020 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Mr. Yossi Ben Shalom as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 16,076,541 | 663,626 | 4,020 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To approve the compensation of Mr. Ami Boehm, in his capacity as Chairman of the Board of Directors, on the terms described in the Proxy Statement.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 16,605,894 | 129,909 | 8,384 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) To approve the compensation of Dr. David Zacut, for his role as a special consultant to the Company, on the terms described in the Proxy Statement.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 15,949,090 | 788,077 | 9,426 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) to approve the terms of compensation of Mr. Hadar Levy, the Company's Chief Executive Officer, on the terms described in the Proxy Statement.

---

| | | |
|:---|:---|:---|
| **Votes in Favor (excluding shareholders indicating personal interest)** | **Votes Against** | **Abstentions** |
| 8,319,463 | 131,039 | 9,426 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) to approve an amendment of the Compensation Policy of the Company as set forth in the Proxy Statement.

---

| | | |
|:---|:---|:---|
| **Votes in Favor (excluding shareholders indicating personal interest)** | **Votes Against** | **Abstentions** |
| 9,792,723 | 684,838 | 5,648 |

---

 **

***Incorporation by Reference***

 **

The contents of this Form 6-K are incorporated by reference in the Company's registration statement on Form F-3, on September 17, 2021 (Registration No. 333-259610), and Form S-8, SEC Registration No. 333-230979, filed by the Company with the SEC on April 22, 2019, and shall be a part thereof from the date on which this Form 6-K is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

**Signatures**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>Date: March 20, 2023 | **BRAINSWAY LTD.**<br>By: /s/ *Ami Boehm*<br>|
|  | Ami Boehm, Chairman of the Board of Directors |

---